RYR2 and catecholaminergic polymorphic ventricular tachycardia: For instance, gain-of-function mutations in RyR2 have been shown to predispose to catecholaminergic polymorphic ventricular tachycardia and AF by enhanced propensity for spontaneous Ca(2+) release [19].